Description
P2.03 Immunomodulatory Drugs Restore Effector Cell Immune Functions In Myeloma Patients With Low Disease Burden After Autologous Stem Cell Transplantation
Article: P2.03 Immunomodulatory Drugs Restore Effector Cell Immune Functions In Myeloma Patients With Low Disease Burden After Autologous Stem Cell Transplantation
€2.42
Related products
-
Article: Highlights in squamous cell carcinoma of the head and neck
€2.42 Add to cart -
Article: Highlights in squamous cell carcinoma of the head and neck
€2.42 Add to cart -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€2.42 Add to cart -
Article: Highlights in digestive oncology
€2.42 Add to cart
